Live Breaking News & Updates on Karolinska Institutet Department Of Clinical Neuroscience

Stay updated with breaking news from Karolinska institutet department of clinical neuroscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Karolinska Development AB (publ): Karolinska Development's portfolio company OssDsign completes patient enrolment to the TOP FUSION study

STOCKHOLM, SWEDEN, April 25, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company OssDsign has enrolled all patients in the clinical study TOP FUSION, which ....

Karolinska Institutet , Johan Dighed , Viktor Drvota , Investment Fund , Karolinska Development Ab Nasdaq Stockholm , Karolinska Development , Nasdaq Stockholm , Ossdsign Catalyst , General Counsel ,

Karolinska Development AB (publ): Karolinska Development's portfolio company Promimic's IPO offering fully subscribed

STOCKHOLM, Sweden, April 25, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Promimic's IPO offering was fully subscribed. Promimic is now provided with ....

Karolinska Institutet , Johan Dighed , Viktor Drvota , Chalmers University Of Technology , Karolinska Development Ab Nasdaq Stockholm , Karolinska Development , Nasdaq Stockholm , Nasdaq First North Growth , Nasdaq First North Growth Market , General Counsel , Chalmers University ,

Nasdaq Stockholm AB: Delisting of paid subscription shares in (BTA) Karolinska Development AB (publ) (10/22)

The paid subscription shares in Karolinska Development AB will be delisted.
Last trading day for KDEV BTA will be on February 24, 2022. Instrument Paid subscription shares
-
Short ....

Karolinska Development , Issuer Surveillance ,

Karolinska Development AB (publ): The rights issue is registered and the trading in Paid Subscription Shares ceases

Karolinska Development AB (publ) ("Karolinska Development" or the "Company") has completed a rights issue of shares that closed on February 2, 2022. The rights issue is now registered with the Swedish ....

Karolinska Institutet , Viktor Drvota , Swedish Companies Registration Office , Karolinska Development Ab Nasdaq Stockholm , Karolinska Development , Nasdaq Stockholm ,

Karolinska Development AB (publ): Karolinska Development's portfolio company AnaCardio raises SEK 33 million to progress clinical development of a novel therapy for heart failure

STOCKHOLM, SWEDEN February 3, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company AnaCardio has completed a fundraising of SEK 33 million comprised of a ....

Karolinska Institutet , Johan Dighed , Viktor Drvota , Ann Helene Ljungstr , Karolinska Development Ab Nasdaq Stockholm , Karolinska Development , Nasdaq Stockholm , General Counsel ,